NASDAQ : SNES

SenesTech, Inc. — News

$1.29 USD

$0.02 (1.57%)

Volume
37.96K
Average Volume
78.95K
Market Capitalization
$6.84M
P/E Ratio
-0.94
Dividend Yield
0.00%
Price Target
Year High
$5.35
Year Low
$1.15
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$6.78
Source Headline
SenesTech, Inc. (SNES) Q2 2026 Earnings Call Transcript

SenesTech, Inc. (SNES) Q2 2026 Earnings Call Transcript

seekingalpha.com - 2026-08-06 03:40:07

Senestech Q2 Earnings Call Highlights

SenesTech (NASDAQ: SNES) reported second-quarter 2026 revenue of $770,000, a company record and an increase of 56% from the first quarter and 23% from the prior-year period, as direct management of its Amazon and other e-commerce channels drove growth. President and CEO Michael Edell said the quarter represented the first full period in which the company

defenseworld.net - 2026-08-06 01:03:55

SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth Accelerates

Revenue rose 56% sequentially and gross margin reached a company-record 73.6% in the first full quarter of in-house Amazon management, advancing the Company's intended shift to a scalable, recurring-revenue platform. SURPRISE, Ariz.

prnewswire.com - 2026-08-05 16:05:00

SenesTech Adds Assessment Services to Help B2B Customers Better Understand Rodent Infestations

New assessment services complement existing implementation and deployment services to develop the most effective solution for each customer's rodent problem. SURPRISE, Ariz.

prnewswire.com - 2026-08-05 08:30:00

SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum

Integrated e-commerce strategy drives recurring revenue while supporting long-term growth across consumer and business-to-business markets. SURPRISE, Ariz.

prnewswire.com - 2026-08-03 08:30:00

SenesTech to Report Second Quarter 2026 Financial Results on Wednesday, August 5, 2026

Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, July 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control solutions for managing rodent populations, will report financial results for its second quarter 2026, ended June 30, 2026, after the market close on Wednesday, August 5, 2026.

prnewswire.com - 2026-07-29 16:15:00

SenesTech's Evolve® Delivers Significant Reduction in Rodent Damage at Texas Agricultural Operation

SURPRISE, Ariz., July 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control solutions for managing rodent populations, today announced successful results from the use of Evolve® Rat Birth Control™ at a 400-acre farming operation in Dalhart, Texas, where rodents had been causing persistent damage to underground irrigation infrastructure.

prnewswire.com - 2026-07-09 08:30:00

SenesTech Appoints Jack Karabees as Executive Vice President of Sales

Veteran enterprise sales executive brings decades of experience scaling companies and leading successful commercial organizations SURPRISE, Ariz., June 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control solutions for managing rodent populations, today announced the appointment of Jack Karabees as Executive Vice President of Sales.

prnewswire.com - 2026-06-29 08:30:00

SenesTech Expands Distribution of Evolve® Rodent Birth Control™ into Bermuda

SURPRISE, Ariz., June 4, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced the expansion of its Evolve® Rodent Birth Control™ products into Bermuda through a distribution agreement with Animal and Garden House, marking another step in the Company's growing presence in environmentally sensitive island markets.

prnewswire.com - 2026-06-04 08:00:00

SenesTech Announces Amendment to Equity Incentive Plan Proposal

PHOENIX, June 3, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) ("SenesTech" or the "Company"), today announced that its Board of Directors has approved an amendment to the proposed changes to the Company's 2018 Equity Incentive Plan (the "2018 Plan"), which is being presented for stockholder approval at the Company's 2026 Annual Meeting of Stockholders scheduled for June 9, 2026. As previously disclosed in the Company's definitive Proxy Statement filed on April 29, 2026, stockholders are being asked to approve an amendment to the 2018 Plan to increase the number of shares available for future equity awards.

prnewswire.com - 2026-06-03 16:05:00

SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

SURPRISE, Ariz., May 19, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.

prnewswire.com - 2026-05-19 16:30:00

SenesTech, Inc. (SNES) Q1 2026 Earnings Call Transcript

SenesTech, Inc. (SNES) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-12 21:10:48

SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition

In-house e-commerce transition and new CEO expected to support scalable recurring revenue growth strategy SURPRISE, Ariz., May 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products today announced financial results for the first quarter ended March 31, 2026 and provided an update on the Company's acceleration of revenue under newly appointed Chief Executive Officer, Michael Edell.

prnewswire.com - 2026-05-12 16:05:00

Get SNES Insider Trade Alerts

SNES Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

SNES Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2024-12-13 HC Wainwright & Co. Maintain Buy Buy
2024-12-12 HC Wainwright & Co. Maintain Buy Buy
2024-05-14 HC Wainwright & Co. Maintain Buy Buy